通过将G-四重复向三重复结构转移,对c-Myc瘤基因表达的高度特异性抑制
Journal of medicinal chemistry
|November 12, 2025
概括
新的折叠式三倍体形成寡核酸 (FTFOs) 精确地准瘤基因G-四倍体. 这种创新策略有效地减少了c-Myc的表达,并损害了癌细胞的生长,提供了一个有前途的抗癌疗法.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- G四重复体与瘤基因调节有关.
- 目前针对G-四重复的小分子疗法缺乏序列特异性,导致非目标效应.
- 在癌症治疗中,需要精确的G-四方体向策略.
研究的目的:
- 引入折叠回复三倍体形成的寡核酸 (FTFOs) 作为针对G-四倍体的特定序列替代品.
- 为了研究FTFO与G-quadruplex结构相互作用和调节的机制.
- 评估FTFO在抑制瘤基因表达和抑制癌细胞进展方面的疗效.
主要方法:
- 新型FTFO的设计和合成.
- 物理化学分析以表征FTFO-G-四重复相互作用.
- 生物试验评估FTFO对瘤基因表达 (例如c-Myc) 和癌细胞表型 (生长,移动性) 的影响.
主要成果:
- 有证据表明,FTFO可以有效地展开c-Myc G-quadruplex结构.
- FTFOs形成非正规的三重体,阻断G-四重体DNA与转录因子的相互作用.
- 在Del4等离子体模型中,已识别的FTFO将c-Myc表达率降低了高达80%.
- 观察到癌细胞生长,结合和移动性的显著损害.
- 内源c-Myc表达也被FTFO治疗减少.
结论:
- FTFO代表了一种创新的,特定于序列的策略,用于准G-quadruplex结构.
- FTFO的三重复合形成有效地阻止G-四重复合并抑制瘤基因活动.
- 作为一种针对癌症治疗的有针对性的治疗方法,FTFO具有前途.
相关概念视频
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K


